Phase Ii trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study
Weiss, G.B.; Metch, B.; Von Hoff, D.D.; Taylor, S.A.; Saiers, J.H.
Cancer Treatment Reports 71(12): 1313-1314
1987
ISSN/ISBN: 0361-5960 PMID: 2446753 Document Number: 303782
Document emailed within 1 workday
Related Documents
Cowan, J.D.; Surwit, E.A.; Alberts, D.S.; Boutselis, J.G.; Neilan, B.A. 1986: Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study Cancer Treatment Reports 70(3): 423-424Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Frata, P.; Ponticelli, P.; Cosentino, D.; Buffoli, A.; Di Pilla, A.; Morrica, B.; Palazzi, M. 2008: Radiotherapy resources for the care of head and neck patients in Italy. A survey by the head and neck group of the Italian Association for Radiation Oncology (AIRO) Tumori 94(1): 59-64
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R. 1982: Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study Cancer Treatment Reports 66(7): 1687-1688
Livingston, R.B.; Helibrun, L.; Lehane, D.; Costanzi, J.J.; Bottomley, R.; Palmer, R.L.; Stuckey, W.J.; Hoogstraten, B. 1977: Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group Study Cancer Treatment Reports 61(9): 1623-1629
Marcial, V.A.; Pajak, T.F.; Kramer, S.; Davis, L.W.; Stetz, J.; Laramore, G.E.; Jacobs, J.R.; Al-Sarraf, M.; Brady, L.W. 1988: Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer Seminars in Oncology 15(1): 39-60
Samal, B.; Jones, S.; Brownlee, R.W.; Morrison, F.; Hoogstraten, B.; Caoili, E.; Baker, L. 1978: Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study Cancer Treatment Reports 62(1): 19-22
Inuyama, Y.; Kida, A.; Tsukuda, M.; Kohno, N.; Satake, B. 2001: Late phase Ii study of S-1 in patients with advanced head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(10): 1381-1390
Kodaira, T.; Fuwa, N.; Tachibana, H.; Hidano, S. 2006: Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer Anticancer Research 26(3b): 2265-2268
Oishi, N.; Berenberg, J.; Blumenstein, B.A.; Johnson, K.; Rivkin, S.E.; Bukowski, R.M.; O'Bryan, R.M.; Stephens, R.L.; Quagliana, J.; Saiers, J.H. 1987: Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1307-1308
Goodwin, W.; Stephens, R.; McCracken, J.D.; Groppe, C. 1981: Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study Cancer Treatment Reports 65(3-4): 359
Tu, G.-y.; Xu, Z.-g.; Liu, S.-y. 2009: From head and neck surgery to head and neck oncology: the disciplinary guarantee for comprehensive cancer therapy Zhonghua Zhong Liu Za Zhi 31(11): 877-879
Nakazato, H.; Ichihashi, H.; Kondo, T. 1986: Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(2): 308-318
Ahnen, D.J.; Feigl, P.; Quan, G.; Fenoglio-Preiser, C.; Lovato, L.C.; Bunn, P.A.; Stemmerman, G.; Wells, J.D.; Macdonald, J.S.; Meyskens, F.L. 1998: Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study Cancer Research 58(6): 1149-1158
Vogl, S.E.; Camacho, F.J.; Kaplan, B.H.; O'Donnell, M.R. 1984: Phase Ii trial of vindesine in advanced squamous cell cancer of the head and neck Cancer Treatment Reports 68(3): 559-560